The start-up is currently backed by Tata Group, Reliance Digital Health and Rakuten Medical, along with a number of eminent industrialists such as Ratan Tata and Venu Srinivasan
Oncology focused, managed healthcare platform Karkinos Healthcare has raised an undisclosed amount of funding from Endiya Partners. The start-up is currently backed by Tata Group, Reliance Digital Health and Rakuten Medical, along with a number of eminent industrialists such as Ratan Tata and Venu Srinivasan.
Karkinos Healthcare is working towards strengthening of the distributed cancer care network model in India, addressing clinical needs that will bring quality care closer to cancer patients. According to reports published by World Health Organization (WHO), one in every ten Indians is estimated to get cancer during their lifetime. Over 70% of cancer cases in India are detected late, leading to poor health outcomes and survival rates.
Karkinos Healthcare started its operations in Kerala, and is looking to expand to Tamil Nadu, Maharashtra, Karnataka and West Bengal. The company works with multiple healthcare institutions and professionals in the oncology ecosystem.
R. Venkataramanan, Founder and CEO, Karkinos Healthcare said, “Endiya Partners, has been a premier early-stage investor in the digital health space, right from the inception with investments in various subsectors of healthtech like AI in Radiology, AI in Pathology, Cell therapy for hitherto untreatable diseases, and tech-driven diabetes management/reversal program etc. Their investment in Karkinos is a strong validation of our pioneering effort to create a distributed cancer care network and we are thrilled to have them as a partner in our crusade against cancer. Cancer care continues to be one of the most critical and yet underserved needs and we are focused on scaling our presence in relevant parts of the country.”
Dr Ramesh Byrapeneni, Managing Director, Endiya Partners said, “Innovative tech startups in the Cancer care space which help drive quality diagnostics and treatment to a larger number of patients, is the need of the hour in India. We strongly feel Karkinos with its comprehensive tech-led solutions and distributed network is poised to bring about the much-needed disruption in the cancer-care ecosystem. We at Endiya Partners, stand by Karkinos, whole-heartedly, and are glad to be a part of their mission.”